Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Synergy appoints Dr Laura Barrow VP of clinical operations

This article was originally published in Scrip

Executive Summary

Synergy Pharmaceuticals, a New York-based developer of drugs to treat gastrointestinal disorders and diseases, has appointed Dr Laura Barrow vice-president of clinical operations. In this newly created position, she will be responsible for Synergy's clinical programmes, including the Phase II/III study of the company's lead drug candidate, plecanatide. Dr Barrow has more than 25 years' pharmaceutical industry experience, having most recently served as worldwide head of clinical and regulatory standard operating procedures at Pfizer. She also spent seven years in clinical research at Roche, and 17 years in project management and organisational effectiveness at Bristol-Myers Squibb.

Advertisement

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC012362

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel